Cost Analyses of Nonoperative Treatment
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ABSTRACT

METHODS

The purpose of this study was to qualitatively review
existing studies that examined cost data within sports
medicine. A literature search was conducted for all
economic studies related to sports-medicine conditions
from 2000 to 2017 within the United States. Area of
analysis, data source utilized, and the type of collected
cost data was identified. There were 29 studies that
met criteria, with the majority of studies (60%) focused
on rotator cuff repair and anterior cruciate ligament
reconstruction. Substantial variability in data source,
practice setting, data metrics, and reported measures
makes interpretation of existing reports challenging.
Greater diversity in topics and more standardized
methodology are necessary to better understand value
and quality in sports medicine.

A literature search was conducted using PubMed,
Embase, Web of Science, and Scopus. Published
economic articles that involved sports-medicine
procedures, diagnostic tests, or treatment options
between January 1, 2000 and December 31, 2017 were
included in the initial search. The search included
both economic and specific terms. The economic
terms were “economic,” “cost,” and “cost analysis.”
The specific terms were “anterior cruciate ligament,”
“ACL,” “posterior cruciate ligament,” “PCL,” “cartilage,”
“meniscus,” “meniscal,” “arthroscopy,” “microfracture,”
“femoroacetabular impingement,” “FAI,” “labrum,”
“rotator cuff,” “instability,” and “tendon.” Articles that
were not cost-identification studies were excluded
from this study, along with any study not based in the
United States. The currency and author affiliation were
both used to determine if a study was a United Statesbased study. Foreign studies were excluded to decrease
study heterogeneity while increasing generalizability
to the United States population. Two of the authors
independently determined study size, time, clinical
area, comparisons, economic data, data source, practice
setting, cost and charge subcategories, findings, and
level of evidence.
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INTRODUCTION
Providing high-value healthcare is a growing priority in
the face of an increasing economic burden associated
with healthcare.1-3 Value is commonly understood to
be the ratio of outcome to cost.4 Although there are
many outcome studies in sports medicine, there are few
cost studies. Such economic studies are challenging to
perform, and there is significant inter-study variation in
region, methodology, and data source. Existing studies
commonly report reimbursement or charges.5 However,
such figures are known to be disparate from actual cost.
Conversion of these data sources to cost is unreliable as
global cost-charge ratios lack adequate granularity.
Cost data that are more reliable and accurate is
necessary. When combined with clinical outcome
data, value and cost effectiveness can be determined.5
Understanding the costs associated with various
interventions is important for patient counseling,
institutional resource allocation, reimbursement, and
practice management. The purpose of this study was to
determine the amount and variety of cost-identification
studies within sports-medicine literature.
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RESULTS
Search Results
The search algorithm identified 1,895 studies. There
were 157 studies (8.28%) related to sports medicine
(Figure 1). Thoroughly assessing abstracts and articles
resulted in a total of 42 cost and economic studies.
When excluding studies that were not based in the
United States, a total of 29 articles (1.53% of the original
search) were to be included in this review (Table 1).
Article references were searched, and the “related
citations” function on PubMed was used. No further
articles were found. Twenty studies (70%) addressed
costs associated with surgical care. Eight studies
(30%) evaluated costs related to diagnostic modalities.

and supplies.7,9-12 Archibald-Seiffer et al8 reported
inter-surgeon variation in suture, instrumentation,
and allograft costs despite all surgeons being in the
same hospital system (Table 1). These studies reported
excellent direct cost data largely centered on time of
surgery, with the exception of one study that evaluated
90-day direct costs for ACLR.14

Figure 1. Study Cohort Flowchart
Only one study focused on the cost associated with
nonoperative treatment for a specific condition.
Eighteen studies (60%) focused on rotator cuff repairs
(RCR) and anterior cruciate ligament reconstruction
(ACLR). Other studies evaluated Achilles tendon
ruptures, various treatments for cartilage lesions, and
diagnostic and follow-up tests.
There was large variation in the cost metrics analyzed
in the studies as well as the sources of collected data
(Table 1). The cost data collected showed a wide variety
between studies ranging from direct and indirect costs,
charges, and reimbursement (Table 1).
Anterior Cruciate Ligament Reconstruction
ACLR was the most common clinical area studied. Of
the 11 ACLR studies, there were 7 studies that presented
cost subcategories (ie, facility, operating room, implant,
graft, and supply fees) in addition to total costs.6-12
One sole study presented therapy fees, and only three
studies presented surgeon and professional fees.6,10,11
Larson et al6 was the only anterior cruciate ligament
study to look at clinical outcome scores along with
cost data.
Two studies examined costs beyond the immediate
encounter for ACLR.13,14 In 4 of 5 studies, allograft
was significantly more expensive than autograft, even
when factoring decreases in operating room time

Rotator Cuff Repair
RCR was also a common clinical area of study. Of the 8
RCR studies, there were 7 studies that presented cost
subcategories in addition to total costs.15-21 Operating
room, implant, graft, and supply fees were the most
common cost subcategories presented. Only one study
included therapy-related costs after RCR (Table 1),15 with
the remainder looking a direct costs centered on time
of surgery.
Similar to ACLR, RCR had high inter-surgeon
variability in supply costs despite being in the same
hospital system.18 Reimbursement for both RCR and
physical therapy afterwards was lower with Medicare
payers than with non-Medicare payers despite similar
costs for RCR.15,17 A study by Bisson et al19 compared
single versus double-row RCR and found the latter
cost to be as high as $5,407 more than the former,
emphasizing the need for a proper cost-effectiveness
analysis (CEA) to evaluate the two techniques. Two
studies looked at the costs for transosseous RCR versus
double-row transosseous equivalent (TOE) surgeries,
and they found the mean implant cost for TOE repairs
to be significantly more expensive than anchorless
repairs, with no difference in operative time or shortterm outcomes (Table 1).16,21 Seidl et al21 was the only
group to associate clinical outcome measures with
cost data among RCR studies. Both studies have good
methodology but were also limited in their cost analysis.
Black et el16 also did not provide any clinical outcome
analysis. These studies would benefit from having a
clear economic model and outcome measure to be able
to perform proper CEA in the future.
Chondral Defects
Only two studies examined treatment of articular
chondral defects. Miller et al22 did a cost analysis
and found similar results between microfracture and
osteochondral allograft transplantation (OAT), with
microfracture being cheaper. However, the cost of OAT
decreased postoperatively at the 10-year follow-up.
Schrock et al23 found microfracture to be more costeffective than osteochondral allograft transplantation or
first-generation autologous chondrocyte implantation,
as measured by cost-per-point change in functional
outcome scores (Table 1). Both of these studies
incorporated clinical outcome measures with direct
costs from surgery thorough an extended follow-up
period.
Nonoperative Management
Only one study included nonoperative management of
Achilles tendon rupture versus surgical management.24
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Table 1. Breakdown of Sports Medicine Cost Analysis Studies from 2000-2017 in the United States
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Study

Clinical Area

Comparison

Study Size

Economic Data

Summary of Economic
Data Presented

Findings

Herzog
et al 201713

ACLR

ACL with or without
other knee injuries

229,446

Charges

Immediate Procedure
Total, 9-month window
total

Concomitant collateral ligament repair
associated with higher costs. Subsequent
procedures were more expensive than the
index procedure.

Rosas et al
201714

ACLR

N/A

10899

Reimbursements

Same-day, 90-day
reimbursements

There is no significant difference in
same-day or 90-day costs between agematched males and females.

Schrock
et al 201723

Cartilage
Defects

Microfracture vs
OAT vs ACI

730

Charges

Procedural, diagnostic
imaging, rehabilitation

Microfracture was found to be
the most cost-effective option.

Truntzer
et al 201724

Achilles
Rupture

Operative vs.
Nonoperative
Management

5,044

Charges

Surgeon, facility, office
visits, physical therapy,
supply, complication

Surgical management of Achilles rupture
was significantly more costly than
nonsurgical management.

Westermann et al
201728

Shoulder
MRI

Urban vs. Critical
Access Hospital
vs. Rural and Rural
Referral Centers

94

Charges

MRI technical costs

Independent imaging centers have
significantly lower charges to consumers
for MRI compared to hospital-owned
centers.

Black et al
201616

RCR

Transosseous
Rotator Cuff Repair
vs Transosseous
Equivalent Rotator
Cuff Repair

344

Direct Costs

Implant Costs, OR Time

Costs associated with arthroscopic
transosseous rotator cuff repair were
lower than costs associated with
transosseous equivalent repairs.

Narvy et al
201617

RCR

Medicare vs. NonMedicare Patients

184

Charges

Implant and Variable
Charges

Reimbursement is lower in the Medicare
group, but charges are similar.

Seidl et al
201621

RCR

Transosseous
Rotator Cuff Repair
vs Transosseous
Equivalent Rotator
Cuff Repair

43

Implant Costs

Implant Costs, OR Time

Mean implant cost lower in the
transosseous rotator cuff repair group
than in the transosseous-equivalent
rotator cuff repair group.

Terhune
et al 201618

RCR

Between Surgeon
Differences

62

Cost

Suture anchors, suturepassing devices,
suture, and disposable
instruments and tools

There is significant variation across
surgeon and case. Suture anchors were
the most expensive and variable surgeondirected cost.

ArchibaldSeiffer et al
20158

ACLR

Surgeon Variation
in Costs for ACL
Reconstruction

49

Limited Direct
Costs

Fixation, Device, Implant,
Supply Cost

Significant variation in cost of tibial or
femoral fixation as well as in cost for
sutures, instruments, and allografts.

Arshi et al
201515

RCR

Medicare vs. United
Healthcare Groups

365,891

Charges

Per-patient average
charge, Utilizationweighted per-patient
average charge

Utilization of physical therapy after
rotator cuff repair is higher in privately
insured than Medicare patients. Perpatient charges are similar between
groups.

Bisson et al
201519

RCR

Single Row vs.
Double Row vs.
Suture Bridge

N/A Cost
Modelling

Calculated
Costs

Implant, Professional
Fee, Anesthesia Fee,
Opportunity Cost,
Therapy Fee

Double row and suture bridge techniques
are more expensive than the single row
technique. Double row and suture bridge
would need to have significantly lower
revision rates than single row to justify
their increased costs.

Miller et al
201522

Cartilage
Defects

Microfracture vs
OAT for Distal
Femoral Articular
Cartilage Defects

N/A Cost
Modelling

Direct Costs

Anesthesia, OR
fees, Surgeon Fees,
Return Visits, MRI,
Initial procedure cost,
secondary procedure
cost

Net direct costs and cost-effectiveness of
microfracture and OAT are comparable
for distal femur articular lesions.

Stucken
et al 201539

ACL Evaluation

N/A

340

Charges

Radiograph costs

Postoperative radiograph after ACL rarely
resulted in changes in management and
had significant costs.

Greene et
al 201431

Knee
Arthroscopy

N/A

3797

Charges

Discordant diagnosis,
discrepant diagnosis
costs

Routine pathologic examination of knee
arthroscopy specimens rarely altered
management of patients
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Iyengar et
al 201420

RCR

N/A

NR

Estimated
Costs from
Hospital
Charges

Total Hospital Charges

Charges associated with inpatient rotator
cuff repair increased in Nationwide
Inpatient Sample over time. Increase in
healthy patients undergoing rotator cuff
repair in outpatient surgery centers

Kahlenberg
et al 201427

Hip
Evaluation

N/A

78

Charges

Healthcare provider
visits, diagnostic
imaging, conservative
management

There are significant costs associated with
delay to diagnosis of femoracetabular
impingement and labral tears

Voigt et al
201425

Shoulder
and Knee
Evaluation

Diagnostic Office
Arthroscopy vs MRI

705000

Calculated
Costs

Treatment, Complication
Costs

Suggests that Diagnostic Office
Arthroscopy is significantly more costeffective than MRI

Keeney et
al 201329

Hip
Evaluation

Impact vs nonimpact
Hip MRI

218

Procedural
Cost Utility

Cost Utility of MRI

MRI of the hip rarely impacts clinical
decision making independent of hip x-ray.

Yeranosian
et al 201330

Rotator Cuff
Evaluation

N/A

92688

Charges during
90-day period
prior to Rotator
Cuff Repair

Diagnostic Imaging,
Injections, Outpatient
Visits, Physical Therapy,
Laboratory/Preoperative
Studies, Miscellaneous,
Unknown

Majority of preoperative costs comes
from MRI related costs.

Greis et al
20127

ACLR

Allograft vs
Autograft for ACL
Reconstruction

96

Charges,
Direct Costs,
Reimbursement

OR costs, intraoperative
supplies, anesthesia,
pharmacy, recovery, total

Allograft cost was not offset by decrease
in OR time. However, could be costeffective in an outpatient setting

Barrera et
al 201110

ACLR

Allograft vs
Autograft for ACL
Reconstruction

164

Cost and
Calculated
Costs from
Case Details

Supply, Labor, and
Facility Costs

Allograft ACL reconstruction cost
significantly higher than autograft ACL
reconstruction cost

Churchill
and Ghorai
201041

RCR

Mini-open vs. Allarthroscopic

5,224

Charges

Total Charges

Mini-open is cheaper than allarthroscopic. Low and intermediate
volume centers were cheaper than high
volume centers.

Cooper and
Kaeding
20109

ACLR

Allograft vs
Autograft for ACL
Reconstruction

98

Direct Costs

Anesthesia, Pharmacy,
Medical Supply,
Operating Room, and
Recovery Room Costs

Allograft cost was not offset by decrease
in OR and recovery room time.

Brophy et
al 200932

ACLR

Double Bundle vs
Single Bundle ACL
Reconstruction

N/A - Cost
Modelling

Direct Costs

Total estimated hospital
costs

Model predicted that double bundle
technique significantly increased cost of
ACL reconstruction.

Nagda et al
200912

ACLR

Allograft vs
Autograft for ACL
Reconstruction

155

Cost and
Calculated
Costs from
Case Details

Graft, implant, operating
room, recovery room,
anesthesia, supplies costs

Allograft ACL reconstruction is costlier
than autograft ACL reconstruction in the
outpatient setting

Cole et al
200511

ACLR

Allograft vs
Autograft for ACL
Reconstruction

123

Charges

Hospital, Surgical Center,
Pharmacy, Anesthesia,
Anesthesia Supplies,
Radiology, OR supplies,
PACU, Laboratory, Central
supplies, Respiratory
Care, Cast Room, Other
Charges

Allograft ACL reconstruction cost
significantly lower than autograft ACL
reconstruction. Autograft has likely
increased hospital stay

Larson et al
20046

ACLR

Single vs Two
Encounters for
Bilateral ACL
Reconstruction

57

Charges

Total charges, OR
costs, ancillary fees,
anesthesiologist, surgeon,
allograft, equipment,
rehabilitation

Bilateral ACL reconstruction over one
encounter was associated with significant
cost savings versus a two episodes of
unilateral ACL reconstruction

Jari et al
200240

ACLR

Bilateral
Simultaneous
vs. Unilateral
Reconstruction

56

Charges

Hospital

Unilateral ACL reconstruction was
cheaper than bilateral simultaneous ACL
reconstruction, however they not did
report statistical significance.

ACL, anterior cruciate ligament; ACLR, anterior cruciate ligament reconstruction; RCR, rotator cuff repair; MRI, magnetic resonance
imaging
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These authors used a database to compare billing
codes with the assumption that outcomes were similar
between operative and nonoperative groups based on
prior literature.24
Diagnosis
Several studies looked at the diagnostic costs of
different sports-medicine conditions. Two studies
evaluated in-office diagnostic arthroscopy for knee
and shoulder intra-articular injuries. These studies
suggested that diagnostic arthroscopy resulted in
cost savings; however, these studies had no clinical
outcome data using prior studies and used Medicare
billing information for cost data.25,26 Magnetic resonance
imaging (MRI) evaluation and other workup for joint
pain was assessed in four studies.27-30 These studies
reported in their cohorts that the use of MRI as a
screening tool for hip pain is not cost effective, that MRI
accounts for a significant portion of preoperative costs
before RCR, and that independent facility shoulder MRIs
are cheaper than large institutional facility MRIs.28-30
These studies provided no clinical outcome data and
used cost information ranging from Medicare billing
information to direct charges from hospitals and
imaging centers. Greene et al31 reported that routine
pathology specimens following knee arthroscopy was
not cost effective (Table 1).
There has been an increasing amount of cost analysis
studies through the timeline of this study. The data used
for cost analysis is still widely variable over the years,
and quality of data analysis also varies from study to
study. The majority of studies in this review lacked
direct future costs and indirect costs to patients, which
needs to be taken into the total cost equation.

DISCUSSION
In the past 18 years, there have only been 29 sportsmedicine economic studies within the United States.
Over the course of this review, there has been a trend
of increased studies published per year. Economic
studies in sports medicine have mostly focused on RCR
and ACLR. This was also the case for CEA in sports
medicine in a review from 2014.2 There is a large need
for economic studies that evaluate other areas within
sports medicine. Although the studies presented here
provide valuable information, variation in source data
and type of cost data limits the generalizability of their
conclusions.
In many of the included studies, reimbursement
or charges were used in lieu of cost data. However,
charges can be as much as twice or triple the amount
of the actual cost.14 The use of reimbursement is also
limited as the contribution margin (revenue-direct cost)
is highly variable. Furthermore, there are significant
indirect and societal costs that should be accounted for,
including lost wages and productivity, family burden
costs, and other non-medical costs that are deficient in
these studies.5 Direct costs certainly underestimate the
total cost of an illness or treatment. Cost remains the

52

REVIEW ARTICLES • WJO VOL. 9 • 2020

most complex component in value calculation, and
the most complete model should include direct and
indirect costs.5
The variety of settings in these studies also limits
their generalizability to larger populations. Most studies
focused on patients within a single institute or small
region. There were six studies that used large and
privately insured financial databases, which are more
useful when comparing to an entire healthcare system.
However, these databases do have their limitations
such as only accounting for the insured population.
Other studies in this review gathered financial data
from multiple sources such as implant companies and
surgical centers without using any patient information,
whereas one study prospectively questioned patients
about their diagnostic workups and reviewed
their medical records to fully capture all financial
information.19,25,27 Other studies were economic models
rather than observational studies.19,22,32 Regardless of
the design, it should be noted that findings from all
economic studies are difficult to generalize across
different populations. For this reason, the amount and
diversity of economic literature within sports medicine
needs to continue to increase.
Despite the variability and limitations discussed
above, there are some preliminary conclusions that
providers and policy makers can draw to help reduce
their expenditure. Two studies, although from the
same institution, reported significant inter-surgeon
differences in supply costs.8,18 It is unclear whether this
is a widespread practice; however, our institutional
experience suggests that this variability may be
common. Furthermore, similar trends have been
reported in other fields.33-37 Some of this variability
can be mitigated by surgeons choosing less expensive
surgical equipment if they feel it will not negatively
impact patient outcomes. However, most of the
cost information presented here should be used to
further evaluate the cost-effectiveness of their various
interventions. Even though Bisson et al19 found singlerow RCR to be less costly than double-row RCRs,
a CEA will help determine if the decreased revision
rates associated with double-row repairs justifies the
increased cost, as other reports have done with
mixed results.38

CONCLUSION
More economic studies that focus on all possible cost
information are needed to further understand the
economic impact of sports medicine. Future studies
should explore different treatments and diagnostic
options and should try to reproduce previous findings
with different populations. Calculation of indirect and
societal costs of nonoperative treatment for sportsmedicine conditions would also be a useful direction for
future research.
In a healthcare economy with limited resources, it
is important to provide the greatest health benefit at

the lowest possible cost. With a trend toward more
economic studies over the last several years, sports
medicine is moving toward that goal. The biggest
limitation to CEA remains obtaining accurate cost data,
which allows for greater generalizability across different
populations. These existing studies provide a foundation
for future researchers to utilize their results alongside
patient outcome measures to conduct CEA.
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